BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 23230309)

  • 21. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
    Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
    Morine KJ; Qiao X; York S; Natov PS; Paruchuri V; Zhang Y; Aronovitz MJ; Karas RH; Kapur NK
    Circulation; 2018 Jul; 138(5):513-526. PubMed ID: 29487140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
    Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
    Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
    Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.
    Maki T; Nasa Y; Tanonaka K; Takahashi M; Takeo S
    J Pharmacol Exp Ther; 2003 Apr; 305(1):97-105. PubMed ID: 12649357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload.
    Ryan TD; Rothstein EC; Aban I; Tallaj JA; Husain A; Lucchesi PA; Dell'Italia LJ
    J Am Coll Cardiol; 2007 Feb; 49(7):811-21. PubMed ID: 17306712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
    Fraccarollo D; Widder JD; Galuppo P; Thum T; Tsikas D; Hoffmann M; Ruetten H; Ertl G; Bauersachs J
    Circulation; 2008 Aug; 118(8):818-27. PubMed ID: 18678774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Puma deletion delays cardiac dysfunction in murine heart failure models through attenuation of apoptosis.
    Mandl A; Huong Pham L; Toth K; Zambetti G; Erhardt P
    Circulation; 2011 Jul; 124(1):31-9. PubMed ID: 21670227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation.
    Diwan A; Wansapura J; Syed FM; Matkovich SJ; Lorenz JN; Dorn GW
    Circulation; 2008 Jan; 117(3):396-404. PubMed ID: 18178777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The overexpression of Twinkle helicase ameliorates the progression of cardiac fibrosis and heart failure in pressure overload model in mice.
    Tanaka A; Ide T; Fujino T; Onitsuka K; Ikeda M; Takehara T; Hata Y; Ylikallio E; Tyynismaa H; Suomalainen A; Sunagawa K
    PLoS One; 2013; 8(6):e67642. PubMed ID: 23840758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon.
    Klein G; Schaefer A; Hilfiker-Kleiner D; Oppermann D; Shukla P; Quint A; Podewski E; Hilfiker A; Schröder F; Leitges M; Drexler H
    Circ Res; 2005 Apr; 96(7):748-55. PubMed ID: 15761199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
    Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
    Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac-deleterious role of galectin-3 in chronic angiotensin II-induced hypertension.
    González GE; Rhaleb NE; D'Ambrosio MA; Nakagawa P; Liao TD; Peterson EL; Leung P; Dai X; Janic B; Liu YH; Yang XP; Carretero OA
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1287-H1296. PubMed ID: 27496875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression.
    Song X; Qian X; Shen M; Jiang R; Wagner MB; Ding G; Chen G; Shen B
    Biochim Biophys Acta; 2015 Feb; 1853(2):513-21. PubMed ID: 25489662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.
    Rothermund L; Kreutz R; Kossmehl P; Fredersdorf S; Shakibaei M; Schulze-Tanzil G; Paul M; Grimm D
    Am J Hypertens; 2002 Jul; 15(7 Pt 1):644-52. PubMed ID: 12118914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small Endogeneous Peptide Mitigates Myocardial Remodeling in a Mouse Model of Cardioselective Galectin-3 Overexpression.
    Sonkawade SD; Pokharel S; Karthikeyan B; Kim M; Xu S; Kc K; Sexton S; Catalfamo K; Spernyak JA; Sharma UC
    Circ Heart Fail; 2021 Sep; 14(9):e008510. PubMed ID: 34415177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
    Ibarrola J; Matilla L; Martínez-Martínez E; Gueret A; Fernández-Celis A; Henry JP; Nicol L; Jaisser F; Mulder P; Ouvrard-Pascaud A; López-Andrés N
    Sci Rep; 2019 Jul; 9(1):9607. PubMed ID: 31270370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.